The Resistance of Cervical Cancer to Chemotherapy and its Reversal

— —

S. Muthusami (Associate Professor and Head, Cancer Research Centre, Karpagam Academy of Higher Education, Coimbatore, India)

The Resistance of Cervical Cancer to Chemotherapy and its Reversal

Name: The Resistance of Cervical Cancer to Chemotherapy and its Reversal
Price: 334.95 AUD
Availability: OutOfStock
ISBN: 9780443223525

S. Muthusami (Associate Professor and Head, Cancer Research Centre, Karpagam Academy of Higher Education, Coimbatore, India)

$334.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
27 March 2026

Chemotherapy; Gynaecology & obstetrics

Series: Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy

The Resistance of Cervical Cancer to Chemotherapy and its Reversal

Edited by: S. Muthusami (Associate Professor and Head Cancer Research Centre Karpagam Academy of Higher Education Coimbatore India)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 235mm, Width: 191mm,
Weight: 450g
ISBN: 9780443223525
ISBN 10: 0443223521
Series: Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy
Pages: 364
Publication Date: 27 March 2026
Audience: Professional and scholarly , College/higher education , Undergraduate , Further / Higher Education
Format: Hardback
Publisher's Status: Active

Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. He is also involved in the identifying the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) and serving as Associate Professor and Head at Cancer Research Centre working in the area of development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.